Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
Saved in:
| Title: | Binding and neutralizing anti-cytomegalovirus activities in immune globulin products. |
|---|---|
| Authors: | Wang X; Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review, CBER, FDA, United States., Xu Y; Plasma Derivatives Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, CBER, FDA, United States., Scott DE; Plasma Derivatives Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, CBER, FDA, United States., Murata H; Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review, CBER, FDA, United States., Struble EB; Plasma Derivatives Branch, Division of Plasma Protein Therapeutics, Office of Tissues and Advanced Therapies, CBER, FDA, United States. Electronic address: evi.struble@fda.hhs.gov. |
| Source: | Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2017 Nov; Vol. 50, pp. 35-41. Date of Electronic Publication: 2017 Oct 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: England NLM ID: 9004494 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8320 (Electronic) Linking ISSN: 10451056 NLM ISO Abbreviation: Biologicals Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
